nivolumab

November 24, 2015November 24, 2015

Immune Checkpoint Inhibitors in Hodgkin’s Lymphoma Highlighted in New Article

News

Hodgkin’s lymphoma (HL) is a cancer of the immune system where malignant Hodgkin Reed-Sternberg cells are present among immune cells, such as T cells, and use different immunosuppressive mechanisms to evade ... Read more

November 16, 2015

Last Week’s Top-3 Most Read Posts On Lymphoma

Read the Articles Here: Reasons to Participate in a Lymphoma Clinical Trial Hodgkin’s Lymphoma Patient Responds Well to Off-label Therapy with Nivolumab Genentech’s Lymphoma Trial Results to Be Key Focus ... Read more

November 10, 2015November 10, 2015

Hodgkin’s Lymphoma Patient Responds Well to Off-label Therapy with Nivolumab

News

Promising results from what is believed to be the first patient treated with nivolumab after allogeneic stem cell transplantation (alloSCT) has recently been reported in a case study titled “Nivolumab in ... Read more